(2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylic acid, 5mg

[(3-methyl-4-pyridinyl)methyl]amine dihydrochloride, 95.0%, 1g

4-(1,3-Dimethyl-2,3-dihydro-1H-benzimidazol-2-yl)-N,N-diphenylaniline>95.0%(HPLC)(qNMR)1g

Ammonium sulphate, min. 99.5%, pa, ACS, ISO, 25 kg, plastic packaging.

(2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97%, 250mg

(1-Methyl-5-phenyl-1H-pyrazol-4-yl)boronic acid, 95.0%, 250mg

1-Chloro-3-fluoro-5-nitrobenzene, 95.0%, 25g

(S)-3-((Acetamidomethyl)thio)-2-aminopropanoic acid hydrochloride, 95.0%, 100g

Filtration unit with nylon membrane Pore size 0.45 μm, 500 ml, 500 ml, 75 mm, 12 Piece(s)

methyl 1-(2,2-difluoroethyl)-1H-pyrazole-5-carboxylate, 1g

m-Tolyldiethanolamine>98.0%(T)25g

6-(o-tolyl)pyridazin-3(2H)-one, 95.0%, 500mg

2-[3,5-Bis(1-Phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole, 97%, 1g